Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

App attack on high blood pressure: digital tool shows promise

NCT ID NCT06242483

Disease control Sponsor: Hospital Israelita Albert Einstein Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a smartphone app called Elfie to help people with high blood pressure lower their numbers. 930 adults with uncontrolled high blood pressure used the app alongside their usual care or just usual care alone. The goal was to see if the app could help bring down systolic blood pressure (the top number) more effectively.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

930 people

The number who actually took part.

Started

Jun 2024

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 18 years and ≤ 75 years * Male and female patients * Hypertension diagnosis based on the local guidelines criteria * Uncontrolled blood pressure (systolic blood pressure ≥ 140 mmHg) on the screening visit * Patients in whom medication adherence needs to be improved according to the healthcare provider clinical judgment * Use of at least 1 anti-hypertensive medication * Ownership of an active smartphone with operational system iOS (version 13.0 or later) or Android (version 8.0 or later) with access to the internet on 3G, 4G or 5G * Ability to use a smartphone app Exclusion Criteria: * Refusal to provide written informed consent * Current use of a health app with the aim to improve medication adherence and blood pressure control * Illiteracy to read in the local language * Known cognitive decline, dementia, or diagnosis of severe psychiatric conditions (depression, schizophrenia, bipolar disorder) * Known use of illicit drugs or alcoholism * Current participation in a cardiovascular randomized clinical trial * Life expectancy \< 1 year

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hypertension are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hypertension

Contacts and locations

Locations

  • 354 Military Hospital

    Hanoi, Vietnam

  • CETRUS - Diagnostica LTDA

    São Paulo, São Paulo, Brazil

  • Centro de Pesquisa Clínica de Guarulhos

    Guarulhos, São Paulo, Brazil

  • Clínica do Coração - JMF

    Aracaju, Sergipe, Brazil

  • District 4 Hospital

    Ho Chi Minh City, Vietnam

  • Elizabeth Do Espirito Santo Eireli

    Votuporanga, São Paulo, Brazil

  • Gia Dinh hospital

    Ho Chi Minh City, Vietnam

  • Hosp. Universitário UFG

    Goiânia, Goiás, Brazil

  • Hospital Israelita Albert Einstein

    São Paulo, São Paulo, 05652-900, Brazil

  • Hospital Municipal Aparecida de Goiânia

    Goiânia, Goiás, Brazil

  • Hospital Universitário Pedro Ernesto

    Rio de Janeiro, Rio de Janeiro, Brazil

  • Hospital Universitário São Francisco na Providência de Deus

    Bragança Paulista, São Paulo, Brazil

  • NF. Pacheco Cardiologia Humanizada

    Belém, Pará, Brazil

  • National Geriatric Hospital

    Hanoi, Vietnam

  • Nguyen Tri Phuong Hospital

    Ho Chi Minh City, Vietnam

  • Rede AME Saúde

    Recife, Pernambuco, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.